READ HERE for an update on Aetna.

Richard R. Furman, M.D.

Medical Oncology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Biographical Info

Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology.  His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.

For More Videos, please see below:

Lymphoma Cancer Treatment NY - Weill Cornell

Honors and Awards

Charles, Lillian and Betty Neuwirth Clinical Scholar Award, 2004-2006

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Hematology)
American Board of Internal Medicine (Medical Oncology)
Clinical Expertise
Chronic Lymphocytic Leukemia
Waldenstrom's Macroglobulinemia
Non-Hodgkin's Lymphoma
Hodgkin's Disease
Idiopathic Thrombocytopenic Purpura
  • M.D.
    Mount Sinai School of Medicine
  • Attending Physician
    NewYork-Presbyterian Hospital
  • Professor of Medicine
    Weill Cornell Medical College, Cornell University
  • Morton Coleman, M.D. Distinguished Professor of Medicine
    Weill Cornell Medical College, Cornell University
  • Associate Attending Physician
    NewYork-Presbyterian Hospital

Lymphoma Program | Weill Cornell Medicine

Richard Furman, M.D.

We Are Weill Cornell Medicine | Dr. Babacar Cisse

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

AstraZeneca Pharmaceuticals LP
Eli Lilly and Company
MEI Pharma, Inc.
MorphoSys AG
TG Therapeutics
X4 Pharmaceuticals, Inc.
Advisory/Scientific Board Member: 
AbbVie Inc.
BeiGene USA
Genentech, Inc.
Janssen Pharmaceutical Company
Pharmacyclics, Inc.
AstraZeneca Pharmaceuticals LP
Janssen Pharmaceutical Company
Other Interest: 
AstraZeneca Pharmaceuticals LP